Vertex Pharmaceuticals IncorporatedShare Price
|
|
Share Price & Volume
| Previous Close | $441.20 | |
| Open | -0.02% | $441.11 |
| Day Low | -0.80% | $437.67 |
| Day High | +0.22% | $442.15 |
| 52-Week Low | -17.84% | $362.50 |
| 52-Week High | +15.77% | $510.77 |
| Day Volume | 705,253 | |
| Average Volume | 1,444,147 | |
| EPS (TTM) | $15.33 | |
| P/E (TTM) | 28.65x | |
| FWD P/E (NTM) | 23.15x | |
| Next Earnings Date | May 4, 2026 |
| Market Cap | 111,709,705,343 | |
| Shares Outstanding (Millions) | 254,359,728 | |
| Dividend | - | |
| Beta | 0.37 | |
| ROE | 0.23% | |
| ROA | 0.12% |
Analyst Ratings and Price Targets
Current:
$439.18
Average:
$561.95
(+27.95%)
Low:
$441.00
(+0.41%)
High:
$641.00
(+45.95%)
You need to login to see this data
| Morgan Stanley | Maintains | Overweight | $612.00 | +39.35% | Apr 9, 2026 |
| Maxim Group | Upgrades | Buy | $575.00 | +30.93% | Mar 17, 2026 |
| Truist Securities | Maintains | Buy | $525.00 | +19.54% | Mar 10, 2026 |
Headquarters
Boston, MA, USA
Sector
Industry
# of Employees
6,100